Pancreatic Ductal Adenocarcinoma is the most common type of pancreatic cancer, accounting for 95% of all pancreatic cancers. You might be searching for information about this disease because you or a loved one is experiencing some symptoms.
rnrn
In fact, pancreatic ductal adenocarcinoma is a quite insidious disease and usually shows no symptoms in the early stages. Since pancreatic adenocarcinoma constitutes ninety-five percent of malignant pancreatic tumors, early diagnosis is of great importance. As the disease progresses, symptoms such as jaundice, back pain, dark urine, and pale stools may appear. In this article, we will explain what pancreatic ductal adenocarcinoma is, its symptoms, diagnosis, and treatment processes in a clear and understandable manner.
rnrn
rnrn
What is Pancreatic Ductal Adenocarcinoma?
rnrn
Pancreatic ductal adenocarcinoma is the most malignant type of tumor seen in the pancreas and accounts for approximately 95% of all malignant pancreatic tumors. This type of cancer starts from the cells lining the ducts (ducts) in the pancreas and progresses insidiously.
rnrn
rnrn
Structure and Function of the Pancreas
rnrn
The pancreas is a leaf-shaped organ located in the abdominal cavity behind the stomach, approximately 15-20 cm long. This gland, resembling the end of a hockey stick, consists of three main sections: head, body, and tail. The pancreas has both endocrine (internal secretion) and exocrine (external secretion) functions, performing two important tasks.
rnrn
For the digestive system, the pancreas secretes enzymes such as amylase, lipase, and trypsin that help break down food. On the other hand, it has Langerhans islets that produce vital hormones like insulin and glucagon to regulate blood sugar levels. Through this dual function, the pancreas plays a critical role in the metabolic balance of the body.
rnrn
rnrn
Cells Where Ductal Adenocarcinoma Develops
rnrn
As the name suggests, pancreatic ductal adenocarcinoma begins in the cells that line the small ducts (ducts) inside the pancreas. These cells normally help transport digestive fluids produced by the pancreas to the small intestine. However, when mutations occur in these cells for various reasons, uncontrolled growth begins, leading to tumor formation.
rnrn
This type of cancer originates from the exocrine cells found in the pancreas and develops in the pancreatic ducts. Approximately two-thirds of the tumors are located in the head of the pancreas (the part closest to the small intestine), while the remaining are found in the body or tail of the gland.
rnrn
rnrn
Difference Between Pancreatic Adenocarcinoma and Other Tumors
rnrn
Two types of tumors can develop in the pancreas: exocrine tumors and neuroendocrine tumors. Pancreatic ductal adenocarcinoma falls under the exocrine tumor group and constitutes about 93% of pancreatic tumors.
rnrn
Other periampullary tumors (tumors of the distal common bile duct, ampulla of Vater, and duodenum) and pancreatic cystic tumors have different behavior patterns and treatment methods. Particularly, neuroendocrine tumors arise from hormone-producing cells and represent only 5% of all pancreatic tumors.
rnrn
Pancreatic ductal adenocarcinoma progresses more aggressively compared to other tumors and is usually diagnosed in advanced stages. This type of cancer, which often goes asymptomatic in its early stages, can cause symptoms such as digestive issues, jaundice, back pain, and weight loss in later stages.
rnrn
Therefore, pancreatic ductal adenocarcinoma is known as the most common type of pancreatic cancer that progresses insidiously, is difficult to diagnose early, and originates from the cells in the pancreatic ducts.
rnrn
rnrn
Symptoms of Pancreatic Ductal Adenocarcinoma
rnrn
It is quite rare for pancreatic ductal adenocarcinoma to show symptoms in its early stages. However, as the tumor grows and progresses, various symptoms begin to emerge. These symptoms may vary depending on the location of the disease in your body and how advanced it is.
rnrn
rnrn
Painless Jaundice and Itching Skin
rnrn
Jaundice is one of the most common and noticeable symptoms of pancreatic ductal adenocarcinoma. Especially in tumors located in the head of the pancreas, the bile duct gets blocked, leading to yellowing of the skin and the whites of the eyes. This condition, medically referred to as “obstructive jaundice,” usually appears without pain and can be the reason patients seek medical attention. Jaundice is often accompanied by widespread and uncomfortable itching of the skin, which results from bile acids accumulating in the blood irritating the nerve endings in the skin.
rnrn
rnrn
Dark Urine and Pale Stools
rnrn
Jaundice does not occur alone. The bile pigment “bilirubin” that cannot be excreted from the body accumulates in the blood and is attempted to be excreted through urine by the kidneys. As a result, the urine color becomes very dark, resembling “tea or cola color.” Additionally, the stool, which normally gets its brown color from bile pigments, turns pale, resembling “clay” because the bile cannot flow into the intestines. These two symptoms are important signs that can help detect pancreatic cancer in its early stages.
rnrn
rnrn
Loss of Appetite and Weight Loss
rnrn
One of the frequently observed early symptoms in pancreatic cancer patients is loss of appetite and unexplained weight loss. Patients may experience significant weight loss without any apparent reason. This symptom is particularly more common in cancers of the head of the pancreas. Loss of appetite and weight loss may arise from the body’s metabolic response to cancer or as a result of the tumor affecting digestive functions.
rnrn
rnrn
Back Pain and Fatigue
rnrn
As cancer progresses, pain that starts in the upper abdomen and radiates to the back is commonly seen. This pain often worsens at night and can intensify when lying down. In tumors that have spread toward the back of the pancreas, the back pain is more pronounced. Chronic fatigue and weakness are also common symptoms observed in pancreatic cancer patients. Especially in advanced stages of the disease, significant fatigue occurs due to disruptions in the body’s energy balance.
rnrn
rnrn
Digestive Issues and Diarrhea
rnrn
Since the pancreas produces digestive enzymes, various digestive issues arise when the tumor affects this function:
rnrn
- rn
- Bloating and indigestion
- Nausea and vomiting
- Fatty, foul-smelling stools (steatorrhea)
- Severe and persistent diarrhea
rn
rn
rn
rn
rnrn
These symptoms arise from the inability to properly digest food and can contribute to weight loss. Additionally, pancreatic cancer patients may experience changes in bowel movements, leading to diarrhea or constipation.
rnrn
When you notice all these symptoms, especially when typical symptoms like painless jaundice, dark urine, and pale stools are seen together, it is vital to consult a doctor without delay.
rnrn
rnrn
Diagnosis Process and Methods Used
rnrn
Accurate diagnosis of pancreatic ductal adenocarcinoma is vital for appropriate treatment planning. Since symptoms usually appear at advanced stages, various imaging techniques and tests are used for a definitive diagnosis.
rnrn
rnrn
Computed Tomography (CT)
rnrn
Computed tomography is the primary examination method for diagnosing pancreatic cancer. A contrast-enhanced CT scan shows the size, location, and relationship of the tumor with surrounding tissues in detail. It also provides important information for evaluating the operability of the tumor, vascular involvement, and lymph node spread. The accuracy rate of CT scans is 100% for lesions larger than 15 mm. However, for smaller tumors, this rate can drop to 67%.
rnrn
rnrn
Magnetic Resonance Imaging (MRI)
rnrn
MRI provides more detailed imaging of soft tissues and is particularly more sensitive than CT in evaluating possible spread to the liver. It can be used as an alternative for tumors that cannot be detected by CT and is quite successful in showing liver metastases. The accuracy rate of MRI is approximately 83%, and this rate is increasing with technological advancements.
rnrn
rnrn
Endoscopic Ultrasound (EUS)
rnrn
Endoscopic ultrasound is the method with the highest accuracy rate for diagnosing pancreatic cancer (93-100%). EUS provides imaging from a very close angle to the pancreas using a high-frequency ultrasound probe placed at the end of the endoscope. Thus, even lesions smaller than 1 cm that cannot be detected by standard imaging methods can be easily identified.
rnrn
The greatest advantage of EUS is that biopsy can be performed in the same session. Fine needle aspiration biopsies (FNAB) performed under EUS guidance increase diagnostic sensitivity to 85-95% and specificity to 100%. It has superiority over other diagnostic methods, especially in evaluating small tumors.
rnrn
rnrn
Biopsy and Laboratory Tests
rnrn
For a definitive diagnosis, a sample must be taken from the suspicious tissue (biopsy). The most commonly used biopsy method in pancreatic cancer is fine needle aspiration performed under EUS guidance. In this procedure, while the mass is clearly visualized with EUS, a thin needle advanced through the endoscope safely collects cell samples from the mass.
rnrn
Laboratory tests look for tumor markers such as CA 19-9 and CEA. Elevated levels of these markers may indicate pancreatic cancer. Additionally, in cases of bile duct obstruction, abnormal results may also be seen in bilirubin and liver function tests.
rnrn
rnrn
Staging: From 0 to 4
rnrn
Staging of pancreatic cancer is used to understand how advanced the tumor is and to create an appropriate treatment plan. Staging is based on the TNM system (Tumor, Lymph Nodes, Metastasis).
rnrn
rnrn
- rn
- Stage 0: Cancer is limited to the cells in the pancreatic ducts and has not spread to surrounding tissues (carcinoma in situ).
- Stage I: The tumor is limited to the pancreas, with no spread to lymph nodes or distant organs.
- Stage II: The tumor has spread to nearby tissues outside the pancreas or to lymph nodes, but there is no distant metastasis.
- Stage III: Cancer has spread to the major blood vessels or nerves surrounding the pancreas.
- Stage IV: Cancer has spread to distant organs such as the liver and lungs (metastasis).
rn
rn
rn
rn
rn
rnrn
For accurate staging, advanced imaging methods such as CT, MRI, EUS, and sometimes PET-CT are used together.
rnrn
rnrn
Treatment Options and Application Criteria
rnrn
The treatment of pancreatic ductal adenocarcinoma is determined based on the stage of the disease and the overall health status of the patient. The correct treatment approach is crucial for extending the patient’s lifespan and improving their quality of life.
rnrn
rnrn
Surgical Intervention (Whipple Surgery)
rnrn
Whipple surgery is the most effective treatment method for pancreatic cancer. In this procedure, the head of the pancreas, duodenum, gallbladder, and a portion of the bile duct are removed. The remaining organs are then reconnected to preserve the function of the digestive system. This highly complex surgery requires significant expertise, so it is important to be performed in specialized centers. According to statistics, only 15-20% of pancreatic cancer patients are in a condition suitable for surgical treatment at the time of diagnosis.
rnrn
rnrn
Chemotherapy and Radiotherapy
rnrn
Chemotherapy is a drug treatment used to destroy cancer cells or stop their growth. Protocols such as Gemcitabine and FOLFIRINOX are frequently used. It can be applied to eliminate microscopic cancer cells remaining after surgery. Radiotherapy works by sending high-energy beams to cancer cells and often yields more effective results when used in conjunction with chemotherapy.
rnrn
rnrn
Immunotherapy and Targeted Treatments
rnrn
In recent years, new developments have emerged in the treatment of pancreatic cancer. Particularly, new targeted therapies have been developed for patients carrying the KRAS G12D mutation (40-45% of cases). New drugs such as INCB161734 and seti-degrasib show exciting results both alone and in combination with chemotherapy. Immunotherapy works by strengthening the body’s immune system against cancer cells and can be evaluated in patients with specific genetic features (such as MSI-H).
rnrn
rnrn
Criteria for Treatment Eligibility
rnrn
When determining treatment options, the following factors are considered:
rnrn
rnrn
- rn
- Size, location, and spread status of the tumor
- Overall health status and age of the patient
- Presence of other accompanying diseases
rn
rn
rn
rnrn
Criteria for surgical eligibility include the degree of tumor involvement with major vessels, whether there is spread to distant organs, and whether the patient is in a condition to tolerate surgery. In patients who are not suitable for surgery, chemotherapy, radiotherapy, or palliative treatments are preferred.
rnrn
rnrn
Post-Treatment Follow-Up Process
rnrn
Regular follow-up after treatment is vital. Patients are called for check-ups every 3-4 months in the first year and every 6 months in subsequent years. During the follow-up process, blood tests (tumor markers such as CA 19-9) and imaging methods (CT, MRI) are used. Additionally, patients who have undergone Whipple surgery may need changes in their dietary habits. Initially, they start with liquid foods and gradually transition to soft and easily digestible foods. Pancreatic enzyme support and insulin treatment, if necessary, are also part of the process.
rnrn
rnrn
Risk Factors and Life Expectancy
rnrn
The risk of developing pancreatic ductal adenocarcinoma is influenced by various factors. Understanding the risk factors and life expectancy is crucial for early diagnosis and appropriate treatment planning.
rnrn
rnrn
Genetic Predisposition and Family History
rnrn
Approximately 10% of pancreatic cancers are hereditary. Individuals with a family history of pancreatic cancer have a higher risk of developing the disease. Especially, those with a family history of pancreatic cancer in first-degree relatives (mother, father, sibling) have a 3-5 times increased risk. More strikingly, individuals with three or more family members with pancreatic cancer may have a risk increase of up to 30 times. Genetic mutations such as BRCA1, BRCA2, and PALB2 are also factors that increase the risk of pancreatic cancer.
rnrn
rnrn
Smoking, Alcohol, and Obesity
rnrn
Smoking is the most significant preventable cause of pancreatic cancer. Studies show that smokers are 2-3 times more likely to develop pancreatic cancer than non-smokers. Additionally, smoking is responsible for approximately 30% of pancreatic cancer cases. Excessive alcohol consumption also increases the risk by 1.5-2 times. Furthermore, obesity is an important risk factor. Each 5-unit increase in body mass index raises the risk of pancreatic cancer by 10%.
rnrn
rnrn
Diabetes and Chronic Pancreatitis
rnrn
Diabetes doubles the risk of developing pancreatic cancer. Interestingly, diabetes can sometimes present as the first symptom of pancreatic cancer. Especially in individuals over 50 years old, sudden onset of diabetes in those without a family history of diabetes may indicate undiagnosed pancreatic cancer. Patients with chronic pancreatitis are also at much higher risk of developing pancreatic cancer. In these patients, the risk is 10-15 times higher compared to healthy individuals.
rnrn
rnrn
Organs Where Metastasis Occurs
rnrn
Pancreatic cancer most frequently metastasizes to the liver. Studies have shown that the rate of liver metastasis can be as high as 83.6%. The second most common site is the lungs (26%). Additionally, the peritoneal cavity (abdominal lining) and distant lymph nodes are also common areas for pancreatic cancer spread. This pattern of spread directly affects the stage of the disease and the treatment plan.
rnrn
rnrn
Factors Affecting Life Expectancy
rnrn
Life expectancy in pancreatic ductal adenocarcinoma depends on many factors. The most important is the stage of the disease. In localized cancer (limited to the pancreas), the 5-year survival rate can be as high as 44%. In cases of regional spread, this rate drops to 15%, and in the presence of distant metastasis, it falls to 3%. The proportion of patients who may be eligible for surgical treatment is only about 10-15%. The patient’s overall health status, tumor characteristics, and response to treatment are other factors that affect life expectancy. The 5-year survival rate for metastatic pancreatic cancer is approximately 3%, and treatment is usually performed with chemotherapy.
rnrn
rnrn
In Summary: Pancreatic Ductal Adenocarcinoma
rnrn
As seen, pancreatic ductal adenocarcinoma is a disease that progresses insidiously and is often diagnosed late. It is vital to notice symptoms such as painless jaundice, back pain, and weight loss. If you experience any of these symptoms, you should consult a doctor without delay.
rnrn
Knowing the risk factors and having regular health check-ups can increase the success of early diagnosis. Lifestyle changes such as reducing smoking and alcohol consumption and maintaining a healthy weight can help lower the risk of the disease. Additionally, individuals with a family history of pancreatic cancer are advised to be more vigilant.
rnrn
Moreover, thanks to advancements in the medical field, diagnostic and treatment options are continuously improving. Surgical intervention, chemotherapy, and newly developed targeted drugs are increasing patients’ lifespan and quality of life. Therefore, early diagnosis, the correct treatment approach, and regular follow-up are key to achieving positive outcomes in pancreatic cancer.
rnrn
In conclusion, being informed about pancreatic cancer and raising awareness is of great importance. This way, you can recognize symptoms early, avoid risk factors, and seek appropriate medical help when necessary. Remember that, as with any disease, early diagnosis can save lives in pancreatic cancer.
rnrn
rnrn
Frequently Asked Questions
rnrn
We have compiled frequently asked questions about pancreatic ductal adenocarcinoma for you. In this section, we answer the most commonly asked questions about the disease.
rnrn
Where does pain occur in pancreatic cancer? Pain is usually felt in the upper abdomen and radiates to the back.
rnrn
Can pancreatic cancer occur at a young age? Although it is mostly seen in older age, it can develop in younger individuals with genetic predisposition.
rnrn
Which blood test indicates pancreatic cancer? There is no single blood test for a definitive diagnosis, but tumor markers such as CA 19-9 and CEA can assist in diagnosis.
rnrn
Can pancreatic cancer be seen on ultrasound? Yes, ultrasound can help detect cancer by creating images of the pancreas. Two types of ultrasound are used: abdominal ultrasound and endoscopic ultrasound.
rnrn
Can pancreatic cancer be cured with surgery? If diagnosed in the early stage, the tumor can be completely removed through surgery, leading to recovery. After Whipple surgery, the patient can return to normal life within about 6 months.
rnrn
Where does pancreatic cancer metastasize first? Cancer can primarily spread within the abdomen and to the liver. It can then jump to the lungs and bones.
rnrn
Pancreatic ductal adenocarcinoma constitutes 95% of pancreatic cancer. Early diagnosis is difficult, with symptoms including jaundice, back pain, and weight loss. Explore treatment options.
rnrn
